Treatment of Renal Transplant Recipients With Low Bone Mineral Density: A Randomized Prospective Trial of Alendronate, Alfacalcidol, and Alendronate Combined With Alfacalcidol-Reference-Cited by-同舟云学术

Treatment of Renal Transplant Recipients With Low Bone Mineral Density: A Randomized Prospective Trial of Alendronate, Alfacalcidol, and Alendronate Combined With Alfacalcidol

Published:2008-01 Issue:1 Volume:40 Page:160-166
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Trabulus S.,Altiparmak M.R.,Apaydin S.,Serdengecti K.,Sariyar M.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference22 articles.

1. Rapid loss of vertebral mineral density after renal transplantation;Julian;N Engl J Med,1991

2. Factors involved in the loss of bone mineral density after renal transplantation;Torregrosa;Transplant Proc,1995

3. Bone mineral density after kidney transplantation;Grotz;Transplantation,1995

4. The medical management of the renal transplant recipient;Braun,2003

5. Osteoporosis after renal transplantation;Trabulus;Nefrologia,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D and organ transplantation;Feldman and Pike's Vitamin D;2024

2. Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: A meta-analysis;Journal of Investigative Medicine;2023-06-30

3. Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-06-22

4. The Effect of Alendronate on Bone Mineral Disorder in Renal Transplant Patients;Transplantation Proceedings;2022-04

5. Glucocorticoid- and Transplantation-Induced Osteoporosis;Endocrinology and Metabolism Clinics of North America;2021-06